Norway selects British-made frigates for its navy, Norwegian government says
Norway will purchase a fleet of British-built frigates to reinforce its naval strength, the government confirmed on Sunday. The move marks a decisive ...
On the sun-soaked southern tip of China, a new kind of medical tourism is quietly unfolding. It’s not about cosmetic surgery or wellness spas but about survival.
Every month, hundreds of desperate cancer patients from across China and increasingly, from Southeast Asia and the Middle East, arrive in Hainan - lured by a unique promise of access to cutting-edge, experimental cancer drugs.
The Boao Lecheng Pilot Zone, a specially designated medical tourism hub in Hainan, is at the heart of this surge. Under a rare regulatory framework approved by Beijing, hospitals and biotech partners here are allowed to import and administer unapproved, investigational drugs - without waiting for the usually lengthy national regulatory approval process.
“We came here because we were out of options,” said Liu Mei, a 47-year-old schoolteacher from Sichuan, whose husband is undergoing treatment for late-stage liver cancer. “This is the only place we could try something new before it’s too late.”
Launched in 2019, the Boao Lecheng zone was envisioned as a sandbox for medical innovation. Today, it houses more than 20 hospitals and clinics, many in partnership with pharmaceutical giants and startups alike. Drugs that have passed safety and efficacy trials overseas - particularly in the US, Japan, and Europe - can be fast-tracked for use here.
One such drug is Tarlatamab, a novel lung cancer therapy developed by Amgen that’s still awaiting full approval in China but is already being used in Boao. For many patients, it’s a last-ditch shot at extending life.
“This model flips the script,” said Dr. Wang Jinxin, oncologist at the Boao Evergrande International Hospital. “We are giving people access to hope — not in five years, but now.”
Yet, the zone’s rapid growth has sparked debate. Critics argue that fast-tracking unapproved drugs risks undermining clinical trial standards and may exploit vulnerable patients.
“This is not a controlled clinical trial , this is compassionate use under a loophole,” said Dr. Li Haoran, a Beijing-based bioethicist.
Patients must sign extensive waivers acknowledging the experimental nature of the drugs. Some pay out of pocket, with costs reaching tens of thousands of yuan per treatment cycle and insurance rarely covers it, yet, many are willing to take that gamble.
“I’m not waiting for paperwork in Beijing while cancer spreads,” said Xu Jinrong, a former logistics worker with advanced gastric cancer. “If I have one chance, I’ll take it.”
The Boao model is also closely being monitored by global pharmaceutical companies. Hainan offers real-world testing environments for their products in a country with a massive patient base - without full regulatory delays.
Some observers believe Hainan’s success could pave the way for regulatory overhauls across China and beyond.
“What’s happening in Hainan is China’s play to become a global hub for medical innovation,” said Daniel Zhang, an analyst at SinoHealth Research. “If it works here, they’ll scale it.”
As Beijing expands the Boao zone and courts more biotech investment, the line between innovation and experimentation may grow thinner. For now, Hainan stands as a unique and controversial experiment in fast-access medicine.
And for those who arrive with hope packed into carry-ons and plastic medical folders, the island offers them the second chance they often can’t find elsewhere.
A powerful eruption at Japan’s Shinmoedake volcano sent an ash plume more than 3,000 metres high on Sunday morning, prompting safety warnings from authorities.
According to the German Research Centre for Geosciences (GFZ), a magnitude 5.7 earthquake struck the Oaxaca region of Mexico on Saturday.
The UK is gearing up for Exercise Pegasus 2025, its largest pandemic readiness test since COVID-19. Running from September to November, this full-scale simulation will challenge the country's response to a fast-moving respiratory outbreak.
A Polish Air Force pilot was killed on Thursday when an F-16 fighter jet crashed during a training flight ahead of the 2025 Radom International Air Show.
Zambia has formalised a strategic partnership with the International Vaccine Institute (IVI) to bolster domestic vaccine manufacturing capacity, the Zambia National Public Health Institute (ZNPHI) announced on Friday.
Four-time Tour de France winner Chris Froome was airlifted to hospital in Toulon after suffering a training crash which left him with broken ribs, a collapsed lung and a back fracture, his team Israel-Premier Tech said on Thursday (August 28).
Bulgaria reported outbreaks of highly pathogenic avian influenza on three farms in the southern part of the country, the World Organisation for Animal Health (WOAH) said on Monday, as Europe faces a seasonal upturn in the deadly disease.
Africa has unveiled a continental emergency preparedness and response plan to tackle cholera from September 2025 to February 2026.
Belarusian President Alexander Lukashenko said on Sunday he had undergone a full medical exam for the first time in his life and was found to be in good health.
You can download the AnewZ application from Play Store and the App Store.
What is your opinion on this topic?
Leave the first comment